Medical devices, healthcare technology and the business of care
PMA approval · P140010

IN.PACT Admiral Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter and IN.PACT 018 Paclitax

Medtronic, Inc. · Decision date Dec 30, 2014

MEDTECHLEDGER EXPLANATIONP140010

What did the FDA approve?

FDA approved PMA P140010 on December 30, 2014, for the IN.PACT Admiral Paclitaxel-Coated PTA Balloon Catheter. The approval statement covers percutaneous transluminal angioplasty after predilatation of de novo or restenotic lesions up to 180 mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4–7 mm.

The applicant was Medtronic, Inc., and the device is classified as a drug-eluting peripheral transluminal angioplasty catheter under product code ONU. The record does not state whether this was an original approval or a supplement, and no supplement type or reason is provided. The statement describes the reported intended use; it does not independently establish safety or clinical effectiveness.

FDA approval order statement

FOR THE IN.PACT ADMIRAL PACLITAXEL-COATED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER. THIS DEVICE IS INDICATED FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY, AFTER PREDILATATION, OF DE NOVO OR RESTENOTIC LESIONS UP TO 180 MM IN LENGTH IN NATIVE SUPERFICIAL FEMORAL OR POPLITEAL ARTERIES WITH REFERENCE VESSEL DIAMETERS OF 4-7 MM.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Dec 30, 2014

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140010
Regulatory pathway
Premarket approval application
Product code
ONU
Decision code
APPR
Decision date
Dec 30, 2014
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug-Eluting Peripheral Transluminal Angioplasty Catheter.

Product code
ONU
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P140010 received

    Application receipt date recorded by FDA.

  2. P140010 · FDA decision

    APPR

  3. P140010/S106 · Related supplement

    IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

Timeline entries are records held by MedtechLedger for P140010. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140010

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementSep 24, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3576 Unocal Pl., Santa Rosa, CA, 95403

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records